These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14051712)

  • 1. [THE DEMONSTRATION OF ANTI-NUCLEAR FACTORS IN THE BLOOD OF PATIENTS WITH LUPUS ERYTHEMATOSUS BY THE FLUORESCENT ANTIBODY TECHNIC. IMMUNO-ELECTROPHORETIC OBSERVATIONS].
    MENEGHINI CL; COZZA G
    G Ital Dermatol; 1963; 104():323-36. PubMed ID: 14051712
    [No Abstract]   [Full Text] [Related]  

  • 2. AUTOIMMUNE GLOBULINS IN SYSTEMIC LUPUS ERYTHEMATOSUS.
    HAMASHIMA Y; ODAKA T
    Jpn J Med Sci Biol; 1964 Oct; 17():267-77. PubMed ID: 14235611
    [No Abstract]   [Full Text] [Related]  

  • 3. [The Jones and Thompson precipitation test and its specificity in systemic lupus erythematosus].
    FERLAZZO B; PUGLISI N; RICCIARDI R; STAITI A
    Riforma Med; 1963 Apr; 77():459-63. PubMed ID: 13944766
    [No Abstract]   [Full Text] [Related]  

  • 4. SLOWLY SEDIMENTING MERCAPTOETHANOL-RESISTANT ANTINUCLEAR FACTORS RELATED ANTIGENICALLY TO M IMMUNOGLOBULINS (GAMMA-1M-GLOBULIN) IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
    ROTHFIELD NF; FRANGIONE B; FRANKLIN EC
    J Clin Invest; 1965 Jan; 44(1):62-72. PubMed ID: 14254257
    [No Abstract]   [Full Text] [Related]  

  • 5. [EXPERIMENTAL PATHOGENETIC STUDIES WITH THE FLUORESCENT ANTIBODY TECHNIC IN LUPUS ERYTHEMATOSUS. APROPOS OF THE UNITARY PATHOGENESIS OF ACUTE AND CHRONIC LUPUS ERYTHEMATOSUS].
    MENEGHINI CL; COZZA G
    G Ital Dermatol; 1964; 105():45-52. PubMed ID: 14135368
    [No Abstract]   [Full Text] [Related]  

  • 6. ANTI-NUCLEAR-FACTORS (ANF) AS DETERMINED BY THE IMMUNO-FLUORESCENT-ANTIBODY TECHNIQUE.
    FABER V; ELLING P
    Acta Med Scand; 1965 Mar; 177():309-19. PubMed ID: 14281788
    [No Abstract]   [Full Text] [Related]  

  • 7. [IMMUNOFLUORESCENT INVESTIGATIONS OF ANTI-NUCLEAR FACTORS IN THE BLOOD OF PATIENTS WITH DISSEMINATED LUPUS ERYTHEMATOSUS AND OF SOME OF THEIR CLOSE RELATIVES].
    CARUNTU F
    Med Interna (Bucur); 1964 Apr; 16():479-86. PubMed ID: 14146029
    [No Abstract]   [Full Text] [Related]  

  • 8. CHARACTERIZATION OF ANTIBODIES IN HUMAN URINE.
    HANSON LA; TAN EM
    J Clin Invest; 1965 May; 44(5):703-15. PubMed ID: 14276128
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunofluorescent patterns and specificity of human antinuclear antibodies.
    Bickel YB; Barnett EV; Pearson CM
    Clin Exp Immunol; 1968 Sep; 3(7):641-56. PubMed ID: 4973611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibodies against native DNA. The methods for their demonstration. Their diagnostic and pathogenetic importance in systemic lupus erythematosus].
    Kostadinova DA; Razboĭnikov S
    Vutr Boles; 1976; 15(2):18-26. PubMed ID: 59467
    [No Abstract]   [Full Text] [Related]  

  • 11. ANTIGEN-ANTIBODY REACTIONS.
    WEIR DM
    Mod Trends Immunol; 1963; 1():53-85. PubMed ID: 14140243
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recognition and demonstration of the serum globulin fractions transporting the antinuclear autoantibodies in lupus erythematous].
    Martina G; Bossi G
    Minerva Dermatol; 1966 Oct; 41(10):346-53. PubMed ID: 4171567
    [No Abstract]   [Full Text] [Related]  

  • 13. FLUORESCENT ANTIBODY STUDIES OF SYSTEMIC LUPUS ERYTHEMATOSUS.
    VAZQUEZ JJ
    Arthritis Rheum; 1963 Aug; 6():SUPPL 536-41. PubMed ID: 14056862
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-DNA factors. Their diagnostic and prognostic importance in diffuse lupus erythematosus].
    Gheorghiu M; Purice S; Ghelerter L
    Stud Cercet Med Interna; 1970; 11(2):139-45. PubMed ID: 4195317
    [No Abstract]   [Full Text] [Related]  

  • 15. [DEMONSTRATION OF THE LE FACTOR BY THE IMMUNOFLUORESCENT METHOD].
    KRAMAR J; STREJCEK J; REJHOLEC V
    Cas Lek Cesk; 1964 Mar; 103():255-8. PubMed ID: 14138932
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus.
    Tan EM; Kunkel HG
    J Immunol; 1966 Mar; 96(3):464-71. PubMed ID: 5932578
    [No Abstract]   [Full Text] [Related]  

  • 17. On the significance of the anti-muscle and erythrocyte membrane factors in systemic lupus erythematosus.
    Arimori S; Nakata Y
    Rev Eur Etud Clin Biol; 1972 Dec; 17(10):970-5. PubMed ID: 4633772
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lupus erythematosus].
    Röckl H
    Z Haut Geschlechtskr; 1971 Oct; 46(19):586-8. PubMed ID: 4109452
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J. Immunol. 1966. 96: 464-471.
    Tan EM; Kunkel HG
    J Immunol; 2006 Feb; 176(3):1297-304. PubMed ID: 16424153
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera.
    Mattioli M; Reichlin M
    J Immunol; 1971 Nov; 107(5):1281-90. PubMed ID: 4330162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.